Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added to the page; no substantive changes to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-01-14T02:58:38.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Locations section expanded with detailed site listings across multiple states and countries, plus a revision tag v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T17:09:55.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page update adds a PubMed auto-fill note indicating publications are drawn from PubMed and may not pertain to the study, and it also introduces a revision tag (v3.3.2). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:24:59.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The government funding lapse notice regarding NIH operations was removed from the page.
    Difference
    0.1%
    Check dated 2025-11-17T19:16:27.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    No new or removed content on the Study Details page for NCT02597933. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T13:44:20.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources; updated to v3.2.0. - Removed a specific resource on Systemic sclerosis and old version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:23:20.000Z thumbnail image

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.